Abstract
Rationale and objectives
Somatostatin (SST) isoforms, SST 14 and SST 28, inhibit regulatory hormones in the periphery (e.g., growth hormone) and are widely distributed in the brain. In recent experiments, intracerebroventricular (ICV) SST produced anxiolytic-like effects in both behavioral and electrophysiological models. The sites of action of these anxiolytic effects in the brain, however, and the relative contributions of SST 14 and SST 28 to these effects are unknown.
Materials and methods
Anxiolytic effects were assessed in the plus-maze and shock-probe tests after (1) intra-amygdalar microinfusion of SST 14 (0.5 or 3 μg per hemisphere) or SST 28 (3 μg per hemisphere), (2) intra-septal microinfusion of SST 14 (0.5 or 1.5 μg per hemisphere) or SST 28 (1.5 μg per hemisphere), or (3) intra-striatal microinfusion of SST 14 (3 μg per hemisphere).
Results
Intra-amygdalar and intra-septal microinfusions of SST 14 and SST 28 produced robust anxiolytic-like effects in the behavioral tests, unlike intra-striatal microinfusions. The magnitude of the anxiolytic effects in the amygdala and septum were comparable to those found previously with ICV SST 14, ICV L-779976, an SST (sst2) receptor agonist, and ICV diazepam, a classical benzodiazepine anxiolytic.
Conclusions
SST receptors in the septum and amygdala are responsive to both SST 14 and SST 28, but not those in the striatum. Although no obvious differences in the anxiolytic-like effects of the isoforms were detected, quantitative or even qualitative differences in their specific anxiolytic effects may occur in different sub-regions of the septum and amygdala, as has been found for benzodiazepine anxiolytics.
Similar content being viewed by others
References
Authier et al (2002) Behavioural assessment of dimethylsulfoxide neurotoxicity in rats. Toxicology Letters 132(2):117–121
Bassant M, Simon A, Poindessous-Jazat F, Csaba Z, Epelbaum J, Dournaud P (2005) Medial septal GABAergic neurons express the somatostatin sst2a receptor: functional consequences on unit firing and hippocampal theta. J Neurosci 25:2032–2041
Batten TFC, Gamboa-Esteves FO, Saha S (2002) Evidence for peptide co-transmission in retrograde and anterograde-labelled central nucleus of amygdala neurones projecting to NTS. Auton Neurosci 98:28–32
Breder CD, Yamada Y, Yasuda K, Seino S, Saper CB, Bell GI (1992) Differential expression of somatostatin receptor subtypes in brain. J Neurosci 12:3920–3934
Brien S, Prescott P, Bashir N, Lewith H, Lewith G (2008) Systematic review of the nutritional supplements dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) in the treatment of osteoarthritis. Osteoarthritis Cartilage 16:1277–1288
Cervia D, Bagnoli P (2007) An update on somatostatin receptor signalling in native systems and new insights on their pathophysiology. Pharmacol Ther 116:322–341
Chrubasik S, Ziegler R (1996) Does the somatostatin analogue pctreotide have a role in pain relief? Pain Clin 8:369–375
De Jong M, Breeman WAP, Bernard HF, Kooij PPM, Slooter GD, Van Eijck CHJ, Kwekkeboom DJ, Valkema R, Macke HR, Krenning EP (1999) Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues. Q J Nucl Med 43:356–366
Degroot A, Treit D (2004) Anxiety is functionally segregated within the septo-hippocampal system. Brain Res 1001:60–71
Dutar P, Vaillend C, Viollet C, Billard JM, Potier B, Carlo AS, Ungerer A, Epelbaum J (2002) Spatial learning and synaptic hippocampal plasticity in type 2 somatostatin receptor knock-out mice. Neuroscience 112:455–466
Engin E, Treit D (2009) Anxiolytic and antidepressant actions of somatostatin: the role of sst2 and sst3 receptors. Psychopharmacology (Berl) 206:281–289
Engin E, Stellbrink J, Treit D (2008) Anxiolytic and antidepressant effects of intracerebroventricularly administered somatostatin: behavioral and neurophysiological evidence. Neuroscience 157:666–676
Gray JA, McNaughton N (2000) The neuropsychology of anxiety: an enquiry into the functions of the septo-hippocampal system, 2nd edn. Oxford University Press, Oxford
Hall T et al (2007) A high performance liquid chromatography assay for monitoring proprotein convertase activity. J Chromatogr A 1148:46–54
Hofland LJ, van Koetsveld PM, Wouters N, Waaijers M, Reubi JC, Lamberts SW (1992) Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells. Endocrinology 131:571–577
Hogg S (1996) A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54:21–30
Karschin A (1995) Molecular single cell analysis intensifies somatostatin type 1 (sst1) receptors to block inward rectifying K+ channels in rat brain oligodendrocytes. Neuroreport 7:121–124
Keppel G, Zedeck S (1989) Data analysis for research design: analysis of variance and multiple regression/correlation approaches. W. H. Freeman, New York
Kreienkamp HJ, Hönck HH, Richter D (1997) Coupling of rat somatostatin receptor subtypes to a G-protein gated inwardly rectifying potassium channel (GIRK1). FEBS Lett 419:92–94
LeDoux J (2000) Emotion circuits in the brain. Annu Rev Neurosci 23:155–184
Leroux P, Quirion R, Pelletier G (1985) Localization and characterization of brain somatostatin receptors as studied with somatostatin-14 and somatostatin-28 receptor radioautography. Brain Res 347:74–84
Mandarino L, Stenner D, Blanchard W, Nissen S, Gerich J, Ling N, Brazeau P, Bohlen P, Esch F, Guillemin R (1981) Nature 291:76–77
McNaughton N, Kocsis B, Hajos M (2007) Elicited hippocampal theta rhythm: a screen for anxiolytic and procognitive drugs through changes in hippocampal function? Behav Pharmacol 18:329–346
Meis S, Sosulina L, Schulz S, Höllt V, Pape HC (2005) Mechanisms of somatostatin-evoked responses in neurons of the rat lateral amygdala. Eur J Neurosci 21:755–762
Moller LN, Stidsen CE, Hartmann B, Holst JJ (2003) Somatostatin receptors. Biochim Biophys Acta 1616:1–84
Nanda SA, Qi C, Roseboom PH, Kalin NH (2008) Predator stress induces behavioral inhibition and amygdala somatostatin receptor 2 gene expression. Genes Brain Behav 7:639–648
Olias G, Viollet C, Kusserow H, Epelbaum J, Meyerhof W (2004) Regulation and function of somatostatin receptors. J Neurochem 89:1057–1091
Patel YC (1999) Somatostatin and its receptor family. Front Neuroendocrinol 20:157–198
Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic, New York
Pellow S, File SE (1986) Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24:525–529
Pesold C, Treit D (1994) The septum and amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res 638:295–301
Pesold C, Treit D (1995) The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res 671:213–221
Pesold C, Treit D (1996) The neuroanatomical specificity of the anxiolytic effects of intra-septal infusions of midazolam. Brain Res 710:161–168
Pinter E, Helyes Z, Szolcsanyi J (2006) Inhibitory effect of somatostatin on inflammation and nociception. Pharmacol Ther 112:440–456
Robbins RJ, Reichlin S (1983) Somatostatin biosynthesis by cerebral cortical cells in monolayer culture. Endocrinol 113:574–581
Saha S, Henderson Z, Batten TF (2002) Somatostatin immunoreactivity in axon terminals in rat nucleus tractus solitarii arising from central nucleus of amygdala: coexistence with GABA and postsynaptic expression of sst2A receptor. J Chem Neuroanat 24:1–13
Santis S, Kastellakis A, Kotzamani D, Pitarokoili K, Kokona D, Thermos K (2009) Somatostatin increases rat locomotor activity by activating sst2 and sst4 receptors in the striatum and via glutamatergic involvement. Naunyn-Schmiedeberg's Arch Pharmacol 379:181–189
Schindler M, Humphrey PPA, Emson PC (1996) Somatostatin receptors in the central nervous system. Prog Neurobiol 50:9–47
Selmer IG, Schindler M, Allen JP, Humphrey PPA, Emson PC (2000) Advances in understanding neuronal somatostatin receptors. Regul Peptide 90:1–18
Semenova S, Hoyer D, Geyer MA, Markou A (2010) Somatostatin-28 modulates prepulse inhibition of the acoustic startle response, reward processes and spontaneous locomotor activity in rats. Neuropeptides 44:421–429
Shin J, Gireesh G, Kim S et al (2009) Phospholipase c β4 in the medial septum controls cholinergic theta oscillations and anxiety behaviors. J Neurosci 29:15375–15385
Sur C, Korn H, Triller A (1994) Colocalization of somatostatin with GABA or glutamate in distinct afferent terminals presynaptic to the Mauthner cell. J Neurosci 14:576–589
Tallman JF, Gallager DW (1985) The GABA-ergic system: a locus of benzodiazepine action. Annu Rev Neurosci 8:21–44
Treit D (1985) Animal models for the study of anti-anxiety agents: a review. Neurosci Biobehav Rev 9:203–222
Treit D, Menard J (1997) Dissociations among the anxiolytic effects of septal, hippocampal, and amygdaloid lesions. Behav Neurosci 111:653–658
Treit D, Menard J (2000) The septum and anxiety. In: Numan R (ed) The behavioral neuroscience of the septal region. Springer, New York, pp 210–233
Treit D, Pinel JPJ (2005) Defensive burying. In: Wishaw IQ, Kold B (eds) The behavior of the laboratory rat. Oxford University Press, New York, pp 353–362
Treit D, Menard J, Royan C (1993) Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44:463–469
Treit D, Engin E, McEown K (2010) Animal models of anxiety and anxiolytic drug action. In: Stein MB, Steckler T (eds) Behavioral neurobiology of anxiety and its treatment. Springer, New York, pp 121–160
Vécsei L, Widerlöv E, Alling C, Zsigó J, Pávó I, Penke B (1990) Somatostatin28(15–28), but not somatostatin28(1–12), affects central monoaminergic neurotransmission in rats. Neuropeptides 16:181–186
Wang HL, Bogen C, Reisine T, Dichter M (1989) Somatostatin-14 and somatostatin-28 induce opposite effects on potassium currents in rat neocortical neurons. Proc Natl Acad Sci USA 86:9616–9620
Wang HL, Dichter M, Reisine T (2000) Lack of cross-desensitization of somatostatin-14 and somatostatin-28 receptors coupled to potassium channels in rat neocortical neurons. Mol Pharmacol 38:357–361
Weckbecker G, Lewis I, Albert R, Schmid HA, Hoyer D, Bruns C (2003) Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat Rev Drug Dis 2:999–1017
Williams G, Ball JA, Lawson RA, Joplin GF, Bloom SR, Maskill MR (1987) Analgesic effect of somatostatin analogue (octreotide) in headache associated with pituitary tumours. Br Med J (Clin Res Ed) 295:247–248
Zingg HH, Patel YC (1982) Processing of synthetic somatostatin-28 and a related endogenous rat hypothalamic somatostatin-like molecule by hypothalamic enzymes. Life Sci 30:525–533
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yeung, M., Engin, E. & Treit, D. Anxiolytic-like effects of somatostatin isoforms SST 14 and SST 28 in two animal models (Rattus norvegicus) after intra-amygdalar and intra-septal microinfusions. Psychopharmacology 216, 557–567 (2011). https://doi.org/10.1007/s00213-011-2248-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-011-2248-x